Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX
· Real-Time Price · USD
1.20
0.04 (3.90%)
At close: Aug 15, 2025, 3:59 PM
1.21
0.83%
After-hours: Aug 15, 2025, 05:57 PM EDT
Rein Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -5.5M | -40.98M | -5.85M | -8.94M | -7.11M | -7.34M | -1.83M | -1.79M | -4.78M | -4.55M | -6.37M | -7.99M | -8.42M | -6.8M | -6.7M | -5.69M | -6.97M |
Depreciation & Amortization | n/a | n/a | n/a | 4K | 59K | 52K | 12K | 12K | 43K | 43K | 43K | 42K | 41K | 40K | 39K | 40K | 2K |
Stock-Based Compensation | 264K | 133K | 508K | 326K | 150K | 270K | 229K | 300K | 391K | 424K | 442K | 528K | 689K | 607K | 660K | 362K | 631K |
Other Working Capital | -1.18M | -796K | 1.22M | 1.6M | 667K | 194K | -359K | -1.27M | 1.03M | -981K | -228K | 1.04M | 82K | -309K | -1.28M | 1.38M | 842K |
Other Non-Cash Items | n/a | 37M | n/a | n/a | n/a | 178K | -43K | -52K | -87K | -123K | -64K | -18K | -3K | 28K | 6K | -309K | 62K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -938K | -964K | 1.52M | 223K | 1.63M | -3.55M | -11K | -1.59M | -229K | -206K | -1.02M | 1.75M | -105K | -131K | -1.26M | 1.83M | -196K |
Operating Cash Flow | -6.17M | -4.81M | -3.82M | -8.39M | -5.27M | -10.39M | -1.64M | -3.12M | -4.66M | -4.41M | -6.97M | -5.68M | -7.8M | -6.25M | -7.26M | -3.76M | -6.48M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5K | -67K | -85K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.94M | -7.81M | -7.39M | -4.71M | -2.75M | -19.72M | -9.98M | -41.12M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | 500K | 8.5M | 7.25M | 6.7M | 12M | 13.25M | 16.36M | 5M | 23.75M | 5.25M | 3.75M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | -96K | 42K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 66K | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | -96K | 542K | 8.5M | 7.25M | 4.76M | 4.18M | 5.86M | 11.65M | 2.25M | 4.09M | -4.8M | -37.46M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1K | n/a | -154K | n/a | n/a | 15.79M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 26K | 47K | n/a |
Financial Cash Flow | 738K | 1K | -446K | n/a | n/a | 15.79M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 26K | 26K | 55.6M |
Net Cash Flow | -5.44M | -4.81M | -4.26M | 9.88M | -5.27M | 5.24M | -1.1M | 5.38M | 2.59M | 355K | -2.79M | 179K | 3.85M | -4M | -3.15M | -8.54M | 11.67M |
Free Cash Flow | -6.17M | -4.81M | -3.82M | -8.39M | -5.27M | -10.39M | -1.64M | -3.12M | -4.66M | -4.41M | -6.97M | -5.68M | -7.8M | -6.25M | -7.26M | -3.83M | -6.56M |